PC
Paul Choi Goldman Sachs Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
26
Avg Return
Past Year
Past Year
6.8%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
26.9%
Neutral
50%
Negative
23.1%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Sell
Downgraded
| $6 |
37%
downside
| 3 | -1.2% |
0
%
| 15 Oct ‘25 5 days ago |
|
|
|
Neutral
Downgraded
| $77 |
38%
upside
| 2 | -44% |
0
%
| 8 Oct ‘25 11 days ago |
|
|
|
Neutral
Initiated
| $20 |
33%
upside
| 1 | – |
–
| 25 Sep ‘25 25 days ago |
|
|
|
Buy
Initiated
| $47 |
20%
upside
| 1 | +0.28% |
0
%
| 17 Sep ‘25 1 month ago |
|
|
|
Sell
Maintained
| $12 |
39%
downside
| 2 | -47% |
0
%
| 25 Jun ‘25 3 months ago |
|
|
|
Buy
Maintained
| $8 |
265%
upside
| 2 | +68% |
0
%
| 16 May ‘25 5 months ago |
|
|
|
Neutral
Maintained
| $5 |
61%
downside
| 3 | – |
–
| 2 May ‘25 5 months ago |
|
|
|
Buy
Maintained
| $52 |
25%
upside
| 1 | +23% |
0
%
| 17 Apr ‘25 6 months ago |
|
|
|
Buy
Maintained
| $21 |
263%
upside
| 1 | +6.3% |
0
%
| 17 Apr ‘25 6 months ago |
|
|
|
Neutral
Maintained
| $12 |
2%
upside
| 2 | – |
–
| 17 Apr ‘25 6 months ago |
|
|
|
Neutral
Maintained
| $3 |
9%
upside
| 2 | – |
–
| 17 Apr ‘25 6 months ago |
|
|
|
Sell
Maintained
| $10 |
2%
upside
| 2 | +14% |
0
%
| 17 Apr ‘25 6 months ago |
|
|
|
Buy
Maintained
| $225 |
7%
upside
| 1 | +67% |
0
%
| 13 Feb ‘25 8 months ago |
|
|
|
Sell
Maintained
| $42 |
36%
downside
| 1 | -31% |
0
%
| 4 Dec ‘24 10 months ago |
|